BBHC
AVNR

Brown Brothers Harriman & Co’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Brown Brothers Harriman & Co’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-500
Closed -$8K – 914
2014
Q4 		$8K Hold
500
– – ﹤0.01% 719
2014
Q3 		$6K Hold
500
– – ﹤0.01% 696
2014
Q2 		$3K Hold
500
– – ﹤0.01% 708
2014
Q1 		$2K Hold
500
– – ﹤0.01% 760
2013
Q4 		$2K Hold
500
– – ﹤0.01% 635
2013
Q3 		$2K Hold
500
– – ﹤0.01% 667
2013
Q2 		$2K Buy
+500
New +$1.72K ﹤0.01% 704

Brown Brothers Harriman & Co's AVNR Position: Q1 2015 in Review

Brown Brothers Harriman & Co sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 500 shares — an estimated $8K sold.

Brown Brothers Harriman & Co first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $8K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Brown Brothers Harriman & Co reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 500 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $8K.
  • Brown Brothers Harriman & Co first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Brown Brothers Harriman & Co's AVANIR PHARMACEUTICALS, INC CL A position peaked at $8K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2015, filed 15 May 2015.